In Johnson & Johnson news, the stock is down 1.3% over the last five trading days, and that makes this the perfect time to buy this dividend aristocrat…
The pullback was caused by two analysts downgrading Johnson & Johnson (NYSE: JNJ) on July 21, but analysts simply don’t know how to value JNJ stock.
BTIG Research downgraded JNJ from “Neutral” to....More>>>
Sometime in the early 1900s, the enterprising owners of a Michigan cigar store took matters into their own hands to shield themselves from the brutal northern winters. Like many other building owners at the time, they stuffed whatever cheap paper materials they could find into the walls.
During the cigar store’s recent demolition, workers discovered that a colorful cardboard....More>>>
Walgreens Boots Alliance (WBA) has been through a tumultuous transition period recently. The company’s purchase of stores from Rite Aid (NYSE:RAD) has provided the catalyst for future growth in a sustained way, but the market hasn’t yet fully respected its potential. After the Q4 report a couple of months ago, I said WBA looked cheap, and the stock is up almost....More>>>
While numerous biotechs work to find the next vaccine for the flu epidemic that wreaked havoc on the U.S. this Winter, Teladoc (TDOC) offers a digital solution that helps prevent the spread of the illness and allow patients to easily get the needed medical care. The stock isn’t cheap, but the best play in telehealth is a proven company now.
Today I’m bringing you a round of good news … and a round of bad news.
The good? So far, this year’s been better than last for dividend hounds (like us) hoping to dodge a nasty payout cut.
According to Standard & Poor’s, 85 American companies cut their payouts in January and February. That’s still a big number, but it’s....More>>>